AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.21X leverage
Performance
- Low
- ₹450
- High
- ₹462
- 52 Week Low
- ₹405
- 52 Week High
- ₹810
- Open Price₹459
- Previous Close₹460
- Volume449,950
Investment Returns
- Over 1 Month + 2.73%
- Over 3 Month -6.92%
- Over 6 Month -11.57%
- Over 1 Year -43.89%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 20.9
- PEG Ratio
- 0.5
- Market Cap Cr
- 7,136
- P/B Ratio
- 2.3
- Average True Range
- 12.32
- EPS
- 20.92
- Dividend Yield
- 0
- MACD Signal
- 0.08
- RSI
- 43.91
- MFI
- 41.17
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹453.35
-7
(-1.52%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹461.62
- 50 Day
- ₹468.68
- 100 Day
- ₹489.28
- 200 Day
- ₹547.01
Resistance and Support
454.95
- R3 472.90
- R2 467.45
- R1 460.40
- S1 447.90
- S2 442.45
- S3 435.40
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results | |
| 2024-11-09 | Quarterly Results | |
| 2024-08-24 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹453 As on 08 November, 2025 | 06:28
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7135.5 Cr As on 08 November, 2025 | 06:28
The P/E ratio of Akums Drugs & Pharmaceuticals is 20.9 As on 08 November, 2025 | 06:28
The PB ratio of Akums Drugs & Pharmaceuticals is 2.3 As on 08 November, 2025 | 06:28
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.